MINI REVIEW
Accepted on 23 Oct 2025
Harnessing IgM for Solid Tumor Therapy: Biology, Engineering Advances, and Translational Challenges
doi 10.3389/fimmu.2025.1712344
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
AntibodyPlus Therapeutics in Oncology: Innovative Mechanisms, Therapeutic Strategies, and Clinical Advances
1,051
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 13 Oct 2025
Biparatopic HER2-targeted nanobody binder synergizes with trastuzumab in resistant tumor cells
doi 10.3389/fimmu.2025.1711448
ORIGINAL RESEARCH
Accepted on 02 Oct 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy
doi 10.3389/fimmu.2025.1711433
- 169 views
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: